Get Help from the Alumni Services of Your Alma Mater
July 11, 2016
FOR IMMEDIATE RELEASE
The Pros in the Know from West Texas A&M take center stage on Lifetime® Television.
(DEERFIELD BEACH, Fla. – PR LOG – July 11, 2016) The Balancing Act® welcomes experts on everything college related, Tuesday, July 12 and July 19, 2016 at 7:30 a.m. (ET/PT) on Lifetime®.
Don’t miss this special guest on The Balancing Act:
Honoring Your Alma Mater – with West Texas A&M University
Most people spend years getting their college degree, but at the right school, education isn’t limited to the classroom. College campuses offer unparalleled opportunities to get involved in social and athletic activities, and the relationships formed during these years often last a lifetime. If you didn’t take advantage of everything your Alma Mater had to offer, it’s not too late. The Pros in the Know from West Texas A&M University join The Balancing Act to offer tips on tapping into alumni events and reliving your college years. For more information, visit www.WTAMU.edu.
About The Balancing Act®
Entering its 8th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings Monday through Friday at 7:30 am (ET/PT) on Lifetime television. For additional information or to view a segment visit: www.thebalancingact.com.
Join the Conversation!
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.